Literature DB >> 1840404

Interactions between atrial natriuretic factor and the autonomic nervous system.

C C Lang1, A D Struthers.   

Abstract

In addition to its natriuretic, hormonal and vascular actions, atrial natriuretic factor (ANF) may interact importantly with the function of the autonomic nervous system. It has been hypothesized that ANF may exert its cardiovascular and possibly renal effects by interfering with autonomic control mechanisms. In, animal experiments the hypotension that is caused by ANF is usually not associated with the expected reflex tachycardia or increased efferent sympathetic activity. Furthermore, bilateral vagotomy can attenuate the hypotensive action of ANF which suggest that ANF may stimulate sympathoinhibitory afferent vagal activity from the cardiopulmonary baroreceptor system. In man, ANF may alter reflexogenic-mediated forearm vascular responses to cardiopulmonary deactivation which suggest that ANF may have an important role as a neuromodulator of autonomic nervous function, a role that could serve to amplify or facilitate the peripheral hormonal actions of ANF. This neuromodulating influence of ANF could be due to several mechanisms: it could modulate baroreflex mechanisms or it could have direct effects on autonomic centres in the brain or it could have effects on peripheral neurotransmission. The role of the autonomic nervous system in modulating the release of ANF remains controversial. Finally, there is growing evidence to suggest that there is a reciprocal interplay between ANF and the sympathetic nervous system in peripheral target tissues which may have important pathophysiological significance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1840404     DOI: 10.1007/bf01819840

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  87 in total

Review 1.  The heart and the atrial natriuretic factor.

Authors:  M Cantin; J Genest
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

2.  Atrial natriuretic factor attenuates carotid baroreflex-mediated cardioacceleration in humans.

Authors:  T J Ebert; A W Cowley
Journal:  Am J Physiol       Date:  1988-04

3.  Central administration of atrial peptide decreases sympathetic outflow in rats.

Authors:  H D Schultz; M K Steele; D G Gardner
Journal:  Am J Physiol       Date:  1990-05

4.  Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.

Authors:  H D Kleinert; T Maack; S A Atlas; A Januszewicz; J E Sealey; J H Laragh
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

5.  Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure.

Authors:  N Katsube; D Schwartz; P Needleman
Journal:  Biochem Biophys Res Commun       Date:  1985-12-31       Impact factor: 3.575

6.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

7.  Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders.

Authors:  J P Koepke; G F DiBona
Journal:  Am J Physiol       Date:  1987-05

8.  Neuronal and cardiovascular responses to ANF microinjected into the solitary nucleus.

Authors:  R Ermirio; P Ruggeri; C E Cogo; C Molinari; F R Calaresu
Journal:  Am J Physiol       Date:  1989-02

9.  Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney.

Authors:  M Marin-Grez; J T Fleming; M Steinhausen
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

10.  Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity.

Authors:  P Thorén; A L Mark; D A Morgan; T P O'Neill; P Needleman; M J Brody
Journal:  Am J Physiol       Date:  1986-12
View more
  4 in total

1.  Profound vagal reactions to brain natriuretic peptide.

Authors:  R I Cargill; P B Clarkson; T M MacDonald; B J Lipworth
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

2.  Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance.

Authors:  C C Lang; T Moreland; A M Choy; T H Pringle; G P McNeill; A D Struthers
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.

Authors:  Andreas L Birkenfeld; Michael Boschmann; Cedric Moro; Frauke Adams; Karsten Heusser; Jens Tank; André Diedrich; Christoph Schroeder; Gabi Franke; Michel Berlan; Friedrich C Luft; Max Lafontan; Jens Jordan
Journal:  J Clin Endocrinol Metab       Date:  2006-09-19       Impact factor: 5.958

Review 4.  Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF.

Authors:  Kieran F Docherty; Muthiah Vaduganathan; Scott D Solomon; John J V McMurray
Journal:  JACC Heart Fail       Date:  2020-10       Impact factor: 12.035

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.